Publications by authors named "Marie Cavarec"
Article Synopsis
- The study investigates whether F18-choline (FCH) PET/CT can effectively replace Tc99m-sestaMIBI (MIBI) SPECT/CT for preoperative imaging of parathyroid adenomas in patients with primary hyperparathyroidism (PHPT).
- It involves a randomized trial across multiple centers in France, enrolling adults eligible for surgery from November 2019 to May 2022, excluding those with prior parathyroid surgery or certain genetic conditions.
- The primary goal is to compare the success rates of minimally invasive parathyroidectomy guided by these imaging techniques, focusing on patients achieving normal calcium levels one month after surgery.
Introduction: Primary hyperparathyroidism (pHPT) is a common endocrine disorder caused by an autonomous overproduction of parathyroid hormone (PTH) by a parathyroid gland. Over the last decade, F-choline (FCH) PET has emerged as a highly performant imaging technique for guiding parathyroidectomy. As cure is the goal of surgery, the main aims of this study were to summarize patient-based sensitivity, positive predictive value (PPV), and cure rate of FCH PET guided surgery in the surgical management of pHPT.
View Article and Find Full Text PDFObjective: To evaluate the malignancy rate of focal thyroid incidentaloma (fTI) in a population of patients undergoing a 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) for a non-thyroid purpose.
Design: We conducted a prospective cohort study from January 2013 to November 2014. All consecutive patients referred for a FDG PET-CT were prospectively screened.
Purpose: In-111 pentetreotide (Octreotide) is highly sensitive for detecting gastroenteropancreatic neuroendocrine tumors and their metastases. However, a lack of landmarks makes it difficult to localize them anatomically. To overcome this difficulty, the authors simultaneously obtained Octreotide and bone tomoscintigrams, in addition to standard planar images.
View Article and Find Full Text PDF